AETERNA ZENTARIS Forum: Community User: Optimus5c5f637f9daf5

4 Euro wir kommen!!!+

Geilo

Jaaaaaaa

Ergebnisse da?

Gibts Studieneegebnisse ?

Wieder schön angezogen! ????

Was ein Tagesverlauf☺

rna Zentaris Inc. has entered into a new at-market-issuance sales agreement, dated April 27, 2017, with H.C. Wainwright & Co. LLC, and it has filed with the Securities and Exchange Commission a prospectus supplement related to sales and distributions of up to a maximum of 2.24 million common shares through at-the-market (ATM) issuances on the Nasdaq Stock Market, up to an aggregate amount of $6,944,000 under the new ATM sales agreement. Wainwright will act as sales agent for any sales made under the new ATM program. The common shares will be sold at market prices prevailing at the time of the sale of the common shares, and, as a result, prices may vary. The new sales agreement and the prospectus supplement supersede and replace the company's prior at-market-issuance sales agreement entered into in April, 2016, as well as its recently filed prospectus supplement dated March 28, 2017. Since April 1, 2016, the company has issued approximately 2.3 million common shares and raised gross proceeds of approximately $7.8-million under its previous sales agreement with Wainwright, of which approximately 600,000 common shares, raising gross proceeds of approximately $1.8-million, were issued and sold under the March 28, 2017, prospectus supplement. The prospectus supplement supplements the base prospectus included in the company's replacement shelf registration statement on Form F-3, as amended (file No. 333-216853), which was declared effective by the Securities and Exchange Commission on April 27, 2017. The 2017 shelf registration statement and the prospectus supplement are available on the SEC's website. Alternatively, Wainwright will provide copies of these documents upon request by contacting H.C. Wainwright & Co., 430 Park Ave., fourth floor, New York, N.Y., 10022, or at placements@hcwco.com

möglich, kann aber auch zum Totalausfall werden. ist halt Zockerei hier...

*schulterzuck*

Es geht los!

@Lithiumnino, genau das fasst es ziemlich genau zusammen. Ist ein Ü-Ei. Ist die Zoptrex-Studie ein Erfolg, dann könnte es gut steigen, ist die Studie ein Fail, dann könnte es gut abschmieren. Surprise!

Lass dich überraschen. ....schnell kann es geschehen das dein Wünsche in Erfüllung gehen. ..;-)

Tendenz?? Durchbruch oder Flop?

Erste Mai Woche

Zop Ergebnisse sollen Ende April verkündet werden.